MedTrace Logo

Mobile Application for Cardiovascular Risk Treatment

NCT05712070 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2023-02-03

No results posted yet for this study

Summary

This study is a randomized, open-label clinical trial to validate the efficacy and safety of smartphone app-guided life style modification for the management of hypertension and hyperlipidemia.

Conditions

Interventions

BEHAVIORAL

App-guided lifestyle modification

Smart watch and smartphone application-based life style modification for 12 weeks

BEHAVIORAL

A book-based self-education of lifestyle modification

A take-home book-based self-education for lifestyle modification

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
54 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-02
Primary Completion
2023-12-30
Completion
2024-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05712070 on ClinicalTrials.gov